Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With...
SchizophreniaPsychotic DisordersThe purpose of this study is to assess the effectiveness and safety of long-acting risperidone given as a once monthly injection to adult patients with schizophrenia or schizoaffective disorder.
A Study Comparing the Efficacy of Long-acting Injectable Risperidone and Olanzapine Tablets in the...
SchizophreniaPsychotic DisordersThe purpose of this study is to document both short-term, as well as long-term efficacy and safety of a long-acting injectable formulation of risperidone, in comparison with olanzapine for the treatment of patients with schizophrenia or schizoaffective disorder.
Evaluation of the Usefulness to Doctors of the Risperdal Consta Treatment Guidebook Over a Three-month...
SchizophreniaPsychotic DisordersThe purpose of this study is to assess the usefulness of the Risperdal® Consta® Treatment Guidebook in helping the doctor switch the adult patient from taking risperidone tablets daily by mouth to taking long-acting risperidone by injection. The study will also evaluate the effectiveness and safety of long-acting risperidone and its effect on patient satisfaction.
A Long Term Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia...
SchizophreniaThe purpose of this study is to document the long term safety of a long-acting injectable formulation of risperidone in the treatment of patients with schizophrenia who have previously been treated with long-acting risperidone. Efficacy will also be evaluated.
Alcohol Use Disorders in Schizophrenia
SchizophreniaMood Disorders2 moreThe purpose of the study is to evaluate a new treatment to help patients who have problems because of their use of alcohol. The treatment is called Behavioral Treatment for Alcohol Abuse in Schizophrenia (BTAAS).We are interested in determining whether BTAAS is more effective in reducing use than a supportive control treatment.
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia...
SchizophreniaThis study will determine the effectiveness of various combinations of psychosocial therapy and risperidone treatment in improving work or school performance in people with first-episode schizophrenia.
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
SchizophreniaThe purpose of this study is to determine whether aripiprazole augmentation is safe and effective in the treatment of clozapine-treated patients with refractory schizophrenia.
Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus
SchizophreniaThis study is a six-week, open label trial of the novel antipsychotic agent, ziprasidone, added to a stable dose of clozapine or olanzapine in 40 diabetes mellitus patients, patients with an impaired fasting glucose or insulin resistance with schizophrenia or schizoaffective disorder. The first two weeks will be a fixed-dose of ziprasidone 40 mg twice a day. During weeks 2-6, the ziprasidone dose may be increased up to 80 mg twice a day.
Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
SchizophreniaTobacco Use DisorderMany individuals with schizophrenia smoke cigarettes but little is known about the factors that control smoking in people with schizophrenia. The purpose of this trial is to evaluate how bupropion, an antidepressant medication, affects smoking behaviors in individuals with schizophrenia who smoke.
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres...
SchizophreniaThe purpose of this study is to evaluate symptomatic remission rate in patients with schizophrenia using long acting risperidone microspheres